SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: This is critically exemplified by the pathophysiology of SCN1A‐deficient epilepsies like Dravet syndrome, where the NaV1.1, preferentially enriched in GABAergic interneurons, is already compromised [49, 50].